These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 2948526)
1. Cold air-induced rhinorrhea and high-dose ipratropium. Ostberg B; Winther B; Mygind N Arch Otolaryngol Head Neck Surg; 1987 Feb; 113(2):160-2. PubMed ID: 2948526 [TBL] [Abstract][Full Text] [Related]
2. Ipratropium nasal spray: a new treatment for rhinorrhea in the common cold. Borum P; Olsen L; Winther B; Mygind N Am Rev Respir Dis; 1981 Apr; 123(4 Pt 1):418-20. PubMed ID: 6452842 [TBL] [Abstract][Full Text] [Related]
3. The effect of ipratropium bromide on nasal hypersecretion induced by methacholine in patients with vasomotor rhinitis. A double-blind, cross-over, placebo-controlled and randomized dose-response study. Sjögren I; Jonsson L; Köling A; Jansson C; Osterman K; Håkansson B Acta Otolaryngol; 1988; 106(5-6):453-9. PubMed ID: 2974675 [TBL] [Abstract][Full Text] [Related]
4. Effectiveness and safety of intranasal ipratropium bromide in common colds. A randomized, double-blind, placebo-controlled trial. Hayden FG; Diamond L; Wood PB; Korts DC; Wecker MT Ann Intern Med; 1996 Jul; 125(2):89-97. PubMed ID: 8678385 [TBL] [Abstract][Full Text] [Related]
5. Control of the hypersecretion of vasomotor rhinitis by topical ipratropium bromide. Dolovich J; Kennedy L; Vickerson F; Kazim F J Allergy Clin Immunol; 1987 Sep; 80(3 Pt 1):274-8. PubMed ID: 2957416 [TBL] [Abstract][Full Text] [Related]
6. Nasal methacholine provocation and ipratropium therapy of perennial rhinitis. Borum P; Larsen FS; Mygind N Acta Otolaryngol Suppl; 1979; 360():35-9. PubMed ID: 156486 [No Abstract] [Full Text] [Related]
7. Ipratropium bromide aqueous nasal spray for patients with perennial allergic rhinitis: a study of its effect on their symptoms, quality of life, and nasal cytology. Meltzer EO; Orgel HA; Bronsky EA; Findlay SR; Georgitis JW; Grossman J; Ratner P; Wood CC J Allergy Clin Immunol; 1992 Aug; 90(2):242-9. PubMed ID: 1386857 [TBL] [Abstract][Full Text] [Related]
8. A double-blind, placebo-controlled study of the safety and efficacy of ipratropium bromide nasal spray versus placebo in patients with the common cold. Dockhorn R; Grossman J; Posner M; Zinny M; Tinkleman D J Allergy Clin Immunol; 1992 Dec; 90(6 Pt 2):1076-82. PubMed ID: 1460211 [TBL] [Abstract][Full Text] [Related]
10. Common cold and high-dose ipratropium bromide: use of anticholinergic medication as an indicator of reflex-mediated hypersecretion. Ostberg B; Winther B; Borum P; Mygind N Rhinology; 1997 Jun; 35(2):58-62. PubMed ID: 9299652 [TBL] [Abstract][Full Text] [Related]
12. Onset and duration of inhibition of ipratropium bromide nasal spray on methacholine-induced nasal secretions. Wagenmann M; Baroody FM; Jankowski R; Nadal JC; Roecker-Cooper M; Wood CC; Naclerio RM Clin Exp Allergy; 1994 Mar; 24(3):288-90. PubMed ID: 8012861 [TBL] [Abstract][Full Text] [Related]
13. A trial of intranasal Atrovent versus placebo in the treatment of vasomotor rhinitis. Knight A; Kazim F; Salvatori VA Ann Allergy; 1986 Nov; 57(5):348-54. PubMed ID: 2946252 [TBL] [Abstract][Full Text] [Related]
14. Use of 0.06% ipratropium bromide nasal spray in children aged 2 to 5 years with rhinorrhea due to a common cold or allergies. Kim KT; Kerwin E; Landwehr L; Bernstein JA; Bruner D; Harris D; Drda K; Wanger J; Wood CC; Ann Allergy Asthma Immunol; 2005 Jan; 94(1):73-9. PubMed ID: 15702820 [TBL] [Abstract][Full Text] [Related]
15. A dose-response study of the efficacy and safety of ipratropium bromide nasal spray in the treatment of the common cold. Diamond L; Dockhorn RJ; Grossman J; Kisicki JC; Posner M; Zinny MA; Koker P; Korts D; Wecker MT J Allergy Clin Immunol; 1995 May; 95(5 Pt 2):1139-46. PubMed ID: 7751531 [TBL] [Abstract][Full Text] [Related]